These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8096148)

  • 1. In vivo 19F nuclear magnetic resonance of a monofluorinated neuroleptic in the rat.
    Günther U; Albert K
    NMR Biomed; 1993; 6(1):27-31. PubMed ID: 8096148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo 19F nuclear magnetic resonance spectroscopy of trifluorinated neuroleptics in the rat.
    Albert K; Rembold H; Kruppa G; Bayer E; Bartels M; Schmalzing G
    NMR Biomed; 1990 Jun; 3(3):120-3. PubMed ID: 2386658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 19F nuclear magnetic resonance spectroscopy of neuroleptics: the first in vivo pharmacokinetics of trifluoperazine in the rat brain and the first in vivo spectrum of fluphenazine in the human brain.
    Bartels M; Günther U; Albert K; Mann K; Schuff N; Stuckstedte H
    Biol Psychiatry; 1991 Oct; 30(7):656-62. PubMed ID: 1958765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive in vivo detection of a fluorinated neuroleptic in the human brain by 19F nuclear magnetic resonance spectroscopy.
    Durst P; Schuff N; Crocq MA; Mokrani MC; Macher JP
    Psychiatry Res; 1990 Dec; 35(2):107-14. PubMed ID: 2100803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton decoupled fluorine nuclear magnetic resonance spectroscopy in situ.
    Berkowitz BA; Ackerman JJ
    Biophys J; 1987 Apr; 51(4):681-5. PubMed ID: 3034345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 19F magnetic resonance imaging and spectroscopy of a fluorinated neuroleptic ligand: in vivo and in vitro studies.
    Arndt DC; Ratner AV; Faull KF; Barchas JD; Young SW
    Psychiatry Res; 1988 Jul; 25(1):73-9. PubMed ID: 3217469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spiperone: a ligand of choice for neuroleptic receptors. 3. Subcellular distribution of neuroleptic drugs and their receptors in various rat brain areas.
    Laduron PM; Janssen PF; Leysen JE
    Biochem Pharmacol; 1978 Feb; 27(3):323-8. PubMed ID: 23128
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxetine and trifluoperazine in human brain: a 19F-nuclear magnetic resonance spectroscopy study.
    Karson CN; Newton JE; Mohanakrishnan P; Sprigg J; Komoroski RA
    Psychiatry Res; 1992 Aug; 45(2):95-104. PubMed ID: 1362616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs.
    Laduron PM; Janssen PF; Leysen JE
    Biochem Pharmacol; 1978 Feb; 27(3):317-21. PubMed ID: 23127
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo 19F NMR chemical-shift imaging of Ancistrocladus species.
    Bringmann G; Wolf K; Meininger M; Rokitta M; Haase A
    Protoplasma; 2001; 218(3-4):134-43. PubMed ID: 11770430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-dimensional chemical shift imaging of fluorinated neuroleptics in rat brain in vivo by 19F NMR rotating frame zeugmatography.
    Nakada T; Kwee IL
    Magn Reson Imaging; 1989; 7(5):543-5. PubMed ID: 2575203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional localization of halopemide, a new psychotropic agent, in the rat brain.
    Loonen AJ; van Wijngaarden I; Janssen PA; Soudijn W
    Eur J Pharmacol; 1978 Aug; 50(4):403-8. PubMed ID: 29759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of timiperone, 4'-fluoro-4-[4-(2-thioxo-1-benzimidazolinyl)piperidino]butyrophenone, a neuroleptic, in the rat on repeated oral dosage.
    Sudo K; Tachizawa H; Sano M
    Xenobiotica; 1981 Oct; 11(10):685-91. PubMed ID: 6119853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 19F and 1H magnetic resonance strategies for metabolic studies on fluorinated xenobiotics: application to flurbiprofen [2-(2-fluoro-4-biphenylyl)propionic acid].
    Wade KE; Wilson ID; Troke JA; Nicholson JK
    J Pharm Biomed Anal; 1990; 8(5):401-10. PubMed ID: 2081200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of dexfenfluramine/d-norfenfluramine concentration in primate brain using 19F NMR spectroscopy.
    Christensen JD; Babb SM; Cohen BM; Renshaw PF
    Magn Reson Med; 1998 Jan; 39(1):149-54. PubMed ID: 9438448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
    Janssen PA; Allewijn FT
    Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain.
    Komoroski RA; Newton JE; Cardwell D; Sprigg J; Pearce J; Karson CN
    Magn Reson Med; 1994 Feb; 31(2):204-11. PubMed ID: 8133756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vivo 19F nuclear magnetic resonance study of isoflurane elimination from the rabbit brain.
    Mills P; Sessler DI; Moseley M; Chew W; Pereira B; James TL; Litt L
    Anesthesiology; 1987 Aug; 67(2):169-73. PubMed ID: 3605743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drugs as markers in identification. Detection of melperon (Buronil) in an adipoceratous corpse].
    Pollak S; Vycudilik W
    Arch Kriminol; 1986; 178(1-2):25-34. PubMed ID: 2876693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
    Arnett CD; Shiue CY; Wolf AP; Fowler JS; Logan J; Watanabe M
    J Neurochem; 1985 Mar; 44(3):835-44. PubMed ID: 2579198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.